|
2025
|
Invention
|
Novel combination therapy of crenolanib and apoptosis pathway agents for the treatment of prolife... |
|
|
Invention
|
Crenolanib for treating flt3 mutated proliferative disorders associated mutations.
The present i... |
|
|
Invention
|
Crenolanib for treating flt3 mutated proliferative disorders relapsed/refractory to prior treatme... |
|
2024
|
Invention
|
Crenolanib for treating flt3 mutated proliferative disorders.
The present invention relates to t... |
|
|
Invention
|
Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative... |
|
2023
|
Invention
|
Crystal forms of crenolanib and methods of use thereof. present invention relates to novel crysta... |
|
|
Invention
|
Method of inhibiting constitutively active phosphorylated flt3 kinase.
The present invention inc... |
|
|
Invention
|
Method of inhibiting mutant c-kit.
The present invention includes a method of reducing or inhibi... |
|
|
Invention
|
Crenolanib combination therapy.
The present invention includes methods for treating a proliferat... |
|
2022
|
Invention
|
Crenolanib for treating trk kinase associated proliferative disorders.
The present invention inc... |
|
|
Invention
|
Crenolanib for treating flt3 mutated proliferative disorders. The present invention relates to th... |
|
|
Invention
|
Novel uses of crenolanib.
The present invention includes methods of monitoring measurable residu... |
|
2021
|
Invention
|
Crenolanib for treating flt3 mutated proliferative disorders associated mutations. The present in... |
|
|
Invention
|
Crystal forms of crenolanib and methods of use thereof. The present invention relates to novel cr... |
|
|
Invention
|
Crenolanib for treating trk kinase associated proliferative disorders. The present invention incl... |
|
|
Invention
|
Crenolanib for treating pain. The present invention includes methods for reducing or eliminating ... |
|
|
Invention
|
Crenolanib for treating pdgfrα mutated proliferative disorders. The present invention includes me... |
|
|
Invention
|
Crenolanib for treating pain.
The present invention includes methods for reducing or eliminating... |
|
|
Invention
|
Crenolanib for treating pdgfr alpha mutated proliferative disorders.
The present invention inclu... |
|
2020
|
Invention
|
Method of inhibiting mutant c-kit. The present invention includes a method of reducing or inhibit... |
|
|
Invention
|
Method of inhibiting constitutively active phosphorylated flt3 kinase. The present invention incl... |
|
|
Invention
|
Novel uses of crenolanib. The present invention includes methods of monitoring measurable residua... |
|
|
Invention
|
Uses of crenolanib. The present invention includes methods of monitoring measurable residual dise... |
|
2019
|
Invention
|
Crenolanib combination therapy. The present invention includes methods for treating a proliferati... |
|
2014
|
Invention
|
Method of inhibiting flt3 kinase. The present invention includes a method of inhibiting or reduci... |
